NINDS Technology Transfer Office NINDS Technology Transfer Office NINDS Technology Transfer Office
Link to NINDS Home Site NINDS TTO Home Page Link to Neuroscience@NIH TTO Forms
About NINDS TTO
For Investigators
For Industry
Available Collaborations and Licenses
Useful Links

Collaboration Opportunities
NINDS Licensing Opportunities

Ongoing NINDS Clinical Trials


Search Licensing
 
Research and Technology Review
 
Licensing Opportunity  (full list)
 
Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation
 
Institute : National Institute of Neurological Disorders and Stroke (NINDS)
 
Description of Invention :
This work describes a novel nucleolar mechanism that controls the cell-cycle progression in CNS stem cells and cancer cells. The inventors identified a novel peptide, nucleostemin, found in the nucleoli of CNS stem cells, embryonic stem cells, and several cancer cell lines and preferentially expressed by other stem cell-enriched populations. When stem cells differentiate, nucleostemin expression decreases rapidly prior to cell-cycle exit both in vitro and in vivo. Depletion or overexpression of nucleostemin reduces cell proliferation in CNS stem cells and transformed cells.

Nucleic acids encoding the polypeptide, vectors incorporating the nucleic acids, and host cells transfected with these nucleic acids are disclosed and claimed. The claimed invention includes methods for regulating cell differentiation, cell proliferation, or both using nucleostemin. Methods for inducing differentiation, inhibiting proliferation, and inducing senescence of a cell by altering the level of a nucleostemin polypeptide and related amino acid sequences are disclosed and claimed. Methods for screening for agents that affect proliferation, differentiation, or senescence of cells are also disclosed and claimed. Further information can be found in Genes Dev. 2002 Dec 1;16 (23):2991-3003.
 
Inventors :
Robert Tsai and Ronald McKay
 
Patent Status :
Patents Pending
 
NIH Reference Number:
E-019-2003/0-US-01 & E-001-2003/0-US-01
 
Portfolios :
Cancer -Therapeutics-Gene Therapy-Genes
Gene Based Therapies -Therapeutics-Gene Therapy-Therapeutic Genes
Internal Medicine-Therapeutics
 
For Additional Information Please Contact:
Norbert J. Pontzer JD PhD, Office of Technology Transfer
Phone: (301)435-5502 Email: pontzern@mail.nih.gov
 
For Additional Information Regarding Collaboration with the Investigator Please Contact:
Laurie Arrants, NINDS Technology Development Coordinator
Phone: 301-435-3112 Email: arrantsL@ninds.nih.gov
 
 
Last Updated: 7/25/2006
 
Contact us at nindstto@ninds.nih.gov
NINDS Home   |  NINDS TTO Home  | NeuroScience@NIH  |   Forms
DHHS   |  NIH  | FirstGov  |   Accessibility |   Privacy   | Site Index